Skip to main content

Table 3 Immunohistochemical staining to each antigen of ESCC tissues

From: Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients

Patients no.

Immunohistochemistry*

HLA class I

URLC10

TTK

KOC1

VEGFR1

VEGFR2

1

+ + +

+ + +

+ + +

+ + +

+ +

+

2

+ + +

+ + +

+ + +

+ + +

+ +

+ +

3

+ + +

+ + +

+ +

+ + +

+

+

4

+ + +

+ + +

+ +

+ + +

+ +

+ +

5

+ + +

+ + +

+ + +

+ + +

+ +

+

6

+ + +

+ + +

+ + +

+ + +

+

+ +

7

+ + +

+ + +

+ + +

+ + +

+ +

+ +

8

+ + +

+ + +

+ +

+ + +

+

+

9

+ + +

+ + +

+ + +

+ + +

+ +

+ +

10

+ + +

+ + +

+ + +

+ + +

+

+

11

+ + +

+ + +

+ + +

+ + +

+ +

+ +

  1. *(+++): strong positive staining of more than 80%.
  2. (++): positive staining of 50-80%, (+): positive less than 50%.
  3. (-): no appreciable staining.